Graf Akcie CCRN (Cross Country Healthcares, Inc.). Diskuze k akciím CCRN. Aktuální informace CCRN.

Základní informace o společnosti Cross Country Healthcares, Inc. (Akcie CCRN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 739.78M
Hodnota podniku (EV) 867.93M
Tržby 1.071B
EBITDA 61.537M
Zisk 34.274M
Růst v tržbách Q/Q 53.07 %
Růst v tržbách Y/Y 25.79 %
P/E (Cena vůči ziskům) 19.88
Forward P/E 4.06
EV/Sales 0.81
EV/EBITDA 14.10
EV/EBIT 20.81
PEG 2.61
Price/Sales 0.69
P/FCF N/A
Price/Book 4.79
Účetní hodnota na akcii 3.94
Hotovost na akcii 0.04
FCF vůči ceně -2.85 %
Počet zaměstnanců 7,487
Tržba na zaměstnance 143.000k
Profit margin -1.55 %
Operating margin 3.94 %
Gross margin 24.24 %
EBIT margin 3.90 %
EBITDA margin 5.75 %
EPS - Zisk na akcii 0.95
EPS - Kvartální růst 193.75 %
EPS - Očekávaný růst příští rok 183.33 %
Return on assets 8.30 %
Return on equity 20.54 %
ROIC -2.78 %
ROCE 11.22 %
Dluhy/Equity 1.31
Čistý dluh/EBITDA 5.85
Current ratio 2.34
Quick Ratio 2.34
Volatilita 6.24
Beta 0.79
RSI 37.58
Cílová cena analytiků 9
Známka akcie (dle analytiků) 2.29
Insider ownership 5.64 %
Institutional ownership 93.46 %
Počet akcií 38.004M
Procento shortovaných akcií 2.02 %
Short ratio 2.46 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2001
Země United States

Finanční výsledky akcie CCRN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$822.224$816.484$865.048$833.537$767.421$617.825
Cost Of Goods Sold$618.215$606.921$636.462$611.802$570.056$460.021
Gross Profit$204.009$209.563$228.586$221.735$197.365$157.804
Research And Development Expenses------
SG&A Expenses$181.959$180.23$187.435$179.82$161.275$141.018
Other Operating Income Or Expenses$-19.914$-24.627$-16.184$-24.904$-5.283$-11.016
Operating Expenses$837.935$829.364$853.3$827.353$746.856$628.293
Operating Income$-15.711$-12.88$11.748$6.184$20.565$-10.468
Total Non-Operating Income/Expense$-8.5$-5.315$-7.447$-1.639$-16.405$-20.85
Pre-Tax Income$-24.211$-18.195$4.301$4.545$4.16$-31.318
Income Taxes$31.732$-2.478$-34.501$-4.186$-0.794$0.216
Income After Taxes$-55.943$-15.717$38.802$8.731$4.954$-31.534
Other Income------
Income From Continuous Operations$-55.943$-15.717$38.802$8.731$4.954$-31.534
Income From Discontinued Operations------
Net Income$-57.713$-16.951$37.513$7.967$4.418$-31.783
EBITDA$-1.175$-0.652$22.573$17.094$30.517$-1.963
EBIT$-15.711$-12.88$11.748$6.184$20.565$-10.468
Basic Shares Outstanding363635323231
Shares Outstanding363636363231
Basic EPS$-1.61$-0.48$1.07$0.25$0.14$-1.02
EPS - Earnings Per Share$-1.61$-0.48$1.01$0.15$0.14$-1.02
# 2020 2019 2018 2017 2016 2015
Current Ratio2.14542.28262.20842.11771.84491.9581
Long-term Debt / Capital0.30270.26320.27960.35830.36520.3509
Debt/Equity Ratio0.43410.38120.4170.57310.63230.5683
Gross Margin24.811925.666526.424726.601725.71825.5419
Operating Margin-1.9108-1.57751.35810.74192.6798-1.6943
EBIT Margin-1.9108-1.57751.35810.74192.6798-1.6943
EBITDA Margin-0.1429-0.07992.60942.05083.9766-0.3177
Pre-Tax Profit Margin-2.9446-2.22850.49720.54530.5421-5.0691
Net Profit Margin-7.0191-2.07614.33650.95580.5757-5.1443
Asset Turnover2.15031.91211.84962.14622.09911.9002
Inventory Turnover Ratio------
Receiveable Turnover4.71084.7944.88454.71845.12515.1892
Days Sales In Receivables77.48176.13774.725977.356971.218770.3385
ROE - Return On Equity-34.2159-7.203116.32265.75163.5049-24.1951
Return On Tangible Equity-483.2255-37.8231119.5673-10516.35-13.511297.5107
ROA - Return On Assets-14.6304-3.68088.29662.24811.3551-9.6988
ROI - Return On Investment-23.8589-5.307311.7593.69092.2251-15.7043
Book Value Per Share4.5586.12476.63324.69414.42364.165
Operating Cash Flow Per Share-0.4342-0.66940.42660.26470.6976-0.4098
Free Cash Flow Per Share-0.3872-0.65710.46530.15820.7706-0.4999